ResearcherResearch Institute in Oncology and HematologyNo recent work listed
David E. Dawe
Matched on ORCID iD 0000-0001-9762-3156; OpenAlex author ID A5088027114. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2021: 1 paper · 2022: 1 paper
Papers 2
- Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy. Co-author DOI 10.1097/coc.0000000000000882↗
- Utility of the modified frailty index in predicting toxicity and cancer outcomes for older adults with advanced pancreatic cancer receiving first-line palliati… Last author DOI 10.1016/j.jgo.2020.07.004↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rebekah Rittberg · 2 shared papers, 2021–2022 · strength 0.34
- Paper Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliat… DOI 10.1097/coc.0000000000000882↗
- Paper Utility of the modified frailty index in predicting toxicity and cancer outcomes for older adults with advanced pancrea… DOI 10.1016/j.jgo.2020.07.004↗
- Christina Kim · 2 shared papers, 2021–2022 · strength 0.34
- Paper Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliat… DOI 10.1097/coc.0000000000000882↗
- Paper Utility of the modified frailty index in predicting toxicity and cancer outcomes for older adults with advanced pancrea… DOI 10.1016/j.jgo.2020.07.004↗
- Erin N. McAndrew · 1 shared paper, 2022 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.